Comparison 10. Diazoxide vs Hydralazine.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Total of serious adverse events	0	0	Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
2 All cause mortality	0	0	Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
3 Non fatal cardiovascular events	0	0	Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
4 Acute Myocardial Infarction	1	52	Risk Ratio (M‐H, Fixed, 95% CI)	0.86 [0.06, 12.98]
5 Witdrawals due to adverse events	0	0	Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
6 Mean change in systolic blood pressure during treatment	1	52	Mean Difference (IV, Fixed, 95% CI)	13.56 [3.06, 24.06]
7 Mean change in diastolic blood pressure during treatment	1	52	Mean Difference (IV, Fixed, 95% CI)	14.67 [8.01, 21.33]
8 Mean change in heart rate during treatment	0	0	Mean Difference (IV, Fixed, 95% CI)	0.0 [0.0, 0.0]